| 國立成功大學 |
2023 |
MiniNet: Dense squeeze with depthwise separable convolutions for image classification in resource-constrained autonomous systems
|
Tseng, F.-H.;Yeh, K.-H.;Kao, F.-Y.;Chen, Chen C.-Y. |
| 臺大學術典藏 |
2022-09-16T08:49:01Z |
A pilot study of metabolomic pathways associated with fatigue in patients with colorectal cancer receiving chemotherapy
|
Chou Y.-J.; Kober K.M.; Yeh K.-H.; Cooper B.A.; CHING-HUA KUO; Lin B.-R.; Kuo T.-C.; Tseng Y.J.; Miaskowski C.; Shun S.-C. |
| 臺大學術典藏 |
2022-09-15T01:09:59Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C.-H.; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Chia-Chi Lin; Bu C.-F.; Yeh K.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:55Z |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
Chia-Chi Lin; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; Yeh K.-H.; Yang C.-H.; Lin J.-T.; Cheng A.-L.; Lee Y.-C. |
| 臺大學術典藏 |
2022-09-15T01:09:55Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Chia-Chi Lin; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:53Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Chia-Chi Lin; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2022-09-06T07:44:02Z |
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas
|
Kuo S.-H.; Chen L.-T.; Yeh K.-H.; MING-SHIANG WU; Hsu H.-C.; Yeh P.-Y.; Mao T.-L.; Chen C.-L.; Doong S.-L.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-09-06T07:43:57Z |
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21 )
|
Yeh K.-H.; Kuo S.-H.; Chen L.-T.; Mao T.-L.; Doong S.-L.; MING-SHIANG WU; Hsu H.-C.; Tzeng Y.-S.; Chen C.-L.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-09-06T07:43:57Z |
Expression of CD86 and increased inflitration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma
|
Kuo S.-H.; Chen L.-T.; Chen C.-L.; Doong S.-L.; Yeh K.-H.; MING-SHIANG WU; Mao T.-L.; Hsu H.-C.; Wang H.-P.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-09-06T07:43:45Z |
Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression
|
Kuo S.-H.; Chen L.-T.; MING-SHIANG WU; Kuo K.-T.; Yeh K.-H.; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; Lin C.-W.; Lin J.-T.; Cheng A.L. |
| 臺大學術典藏 |
2022-09-06T07:43:36Z |
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment
|
Kuo S.-H.; Chen L.-T.; MING-SHIANG WU; Lin C.-W.; Yeh K.-H.; Kuo K.-T.; Yeh P.-Y.; Tzeng Y.-S.; Wang H.-P.; Hsu P.-N.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-09-06T07:43:34Z |
Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma
|
Kuo S.-H.; Yeh P.-Y.; Chen L.-T.; MING-SHIANG WU; Lin C.-W.; Yeh K.-H.; Tzeng Y.-S.; Chen J.-Y.; Hsu P.-N.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-09-06T07:43:16Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo S.-H.; Cheng A.-L.; Lin C.-W.; Hsu C.-H.; MING-SHIANG WU; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:16Z |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma
|
Kuo S.-H.; Weng W.-H.; Chen Z.-H.; Hsu P.-N.; MING-SHIANG WU; Lin C.-W.; Jeng H.-J.; Yeh K.-H.; Tsai H.-J.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-09-06T07:43:12Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
Kuo S.-H.; Yeh K.-H.; MING-SHIANG WU; Lin C.-W.; Hsu P.-N.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-09-06T07:43:05Z |
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance
|
Kuo S.-H.; Chen L.-T.; Lin C.-W.; MING-SHIANG WU; Hsu P.-N.; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; Wang H.-P.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-23T02:35:01Z |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
SUNG-HSIN KUO; Yeh K.-H.; Lin C.-W.; Liou J.-M.; Wu M.-S.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:17Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Yeh K.-H.; Bu C.-F.; Lin C.-C.; Lu Y.-S.; Yang C.-H.; CHIUN HSU; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.; Wu C.-Y.; Chen J.-S.; Li C.-C.; Liu H.-T.; Hsu C.-H.; Lu Y.-S.; Yeh K.-H.; Yang C.-H.; Shen Y.-C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; CHIUN HSU; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C.; Yeh K.-H.; Yang C.-H.; CHIUN HSU; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2022-08-19T00:20:56Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Yeh K.-H.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Shen Y.-C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:55Z |
erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)
|
CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Yeh K.-H. |
| 臺大學術典藏 |
2022-08-19T00:20:54Z |
Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients
|
Yeh K.H.; Hu F.C.; Chang S.Y.; Kao H.F.; Chen Y.C.; Chien S.F.; Chen I.C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:48Z |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity
|
Cheng A.-L.; Wang H.-P.; Tsai H.-J.; Wu M.-S.; Tzeng Y.-S.; Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; CHIUN HSU |
